FREE Account Opening + No Clearing Fees
Loading...
September 25, 2007 - September 28, 2007

Saamya Biotech IPO Latest News Today

Track all the latest updates and news of Saamya Biotech IPO.

  1. Saamya Biotech Management Discussions

    June 17, 2024 9:49:00 PM

    The biotechnology sector is one of the sectors which have contributed to enhancing the global profile of India in the last decade. At the beginning of the decade, this industry began to take shape ...

    Published by : India Infoline
  2. Artiva upsizes IPO to $167 million as NK cell therapy biotech heads to Nasdaq

    July 19, 2024 12:26:00 PM

    Artiva Biotherapeutics has upsized its IPO to $167 million as the allogeneic natural killer (NK) cell therapy prepares to list on the Nasdaq this morning. | The biotech has knocked its share price ...

    Published by : FierceBiotech
  3. Private biotech M&A surges amid difficult IPO market

    July 22, 2024 7:40:00 PM

    Private biotech company acquisitions are on their fastest pace in years, a trend some in the industry say is driven by the abundance of mature, but not yet public, drug startups.

    Published by : BioPharma Dive
  4. Beyond the biotech IPO: a brave new world

    October 12, 2023 9:50:00 PM

    After a decade of significant challenges, biotech's long-term sustainability depends on making fundamental changes to its traditional business model. A commonly held perception in the biotech ...

    Published by : Nature
  5. Acelyrin files IPO � is a biotech comeback on the way?

    July 16, 2024 3:30:00 AM

    Initial public offerings in the biotech sector nosedived last year after ... There�s no indication yet on how much it is looking to raise with the IPO � its filing suggests $100 million ...

    Published by : pharmaphorum
  6. Are biotech IPOs back in fashion?

    February 8, 2023 9:44:00 AM

    There were only 36 biotech IPOs last year, compared with 68 in 2015 and a record 85 in 2014 � and a rebound was expected in 2017. Are biotech IPOs back in fashion? | pharmaphorum Skip to main ...

    Published by : pharmaphorum
  7. Ginkgo Bioworks and Zymergen: A tale of two IPOs ends in bankruptcy

    October 4, 2023 11:33:00 PM

    Ginkgo Bioworks' (NYSE:DNA) announcement of Zymergen's bankruptcy filing on Tuesday highlights how the biotech IPO boom in 2021 has unraveled amid rising interest rates and falling share prices.

    Published by : Seeking Alpha on MSN
  8. Alumis raises $250m in IPO as biotech stock stirs

    June 28, 2024 10:44:00 AM

    The offering is expected to close on 1 July. Earlier this month, the US-based biotech said that it planned to use part of the IPO proceeds to advance its lead asset ESK-001 into multiple Phase III ...

    Published by : Yahoo Finance
  9. Concord Biotech IPO allotment status check online by PAN number on Link Intime - Use THIS direct link

    August 11, 2023 1:25:00 PM

    Concord Biotech IPO GMP According to several websites that track activities in the unregulated market, the Concord Biotech IPO was commanding a grey market premium (GMP) in the range of Rs 145-149 ...

    Published by : MSN
  10. Concord Biotech IPO allotment � how to check allotment, GMP, listing date and more

    August 11, 2023 3:31:00 AM

    Concord Biotech is expected to announce its share allotment status today, August 11. The shares of Concord Biotech were subscribed almost 25 times. The shares are expected to be listed on the ...

    Published by : Business Insider India

Saamya Biotech IPO Alerts

1. Saamya Biotech India Limited IPO - Listing  Friday, October 19, 2007 12:00:00 AM

Saamya Biotech India Limited IPO listing info:

IPO Listing Date: Friday, October 19, 2007
BSE Script Code: 532905
Listing in: B1 Group
ISIN: INE320H01019
Issue Price: Rs 10/- Per Equity Share
Face Value : Rs 10/- Per Equity Share

2. Saamya Biotech India Limited IPO Allotment Status  Thursday, October 18, 2007 10:45:00 AM

IPO Allotment Status is now available online for Saamya Biotech India Limited.

Saamya Biotech India Limited IPO was closed on September 28, 2007.

 

3. Saamya Biotech India Limited IPO listing date & info  Thursday, October 18, 2007 8:36:00 AM

Saamya Biotech India Limited IPO listing info:

IPO Listing Date: Friday, October 19, 2007
BSE Script Code: 532905
Listing in: B1 Group
ISIN: INE320H01019
Issue Price: Rs 10/- Per Equity Share
Face Value : Rs 10/- Per Equity Share

4. Saamya Biotech India Limited IPO - Allotment  Thursday, October 18, 2007 12:00:00 AM

IPO Allotment Status is now available online for Saamya Biotech India Limited.

Saamya Biotech India Limited IPO was closed on September 28, 2007.

5. Saamya Biotech India Limited IPO - Close  Friday, September 28, 2007 12:00:00 AM

Incorporated in 2002, Saamya Biotech India Limited (SBIL) is a Hyderabad based Biotech company. SBIL manufacture and market bio pharmaceutical and recombinant protein products to medical and other industries.

SBIL is entering the capital markets with an initial public offering, IPO of 1,50,00,000 Equity Shares through a Fixed Price Issue.

The price for the issue has been fixed at Rs 10/- for equity share of Rs 10/-. The issue opens on September 25, 2007, and closes for subscription on September 28, 2007. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE).

6. Saamya Biotech India Limited IPO - Open  Tuesday, September 25, 2007 12:00:00 AM

Incorporated in 2002, Saamya Biotech India Limited (SBIL) is a Hyderabad based Biotech company. SBIL manufacture and market bio pharmaceutical and recombinant protein products to medical and other industries.

SBIL is entering the capital markets with an initial public offering, IPO of 1,50,00,000 Equity Shares through a Fixed Price Issue.

The price for the issue has been fixed at Rs 10/- for equity share of Rs 10/-. The issue opens on September 25, 2007, and closes for subscription on September 28, 2007. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE).

7. Saamya Biotech IPO opening on Sept 25  Tuesday, September 18, 2007 2:27:00 PM

Incorporated in 2002, Saamya Biotech India Limited (SBIL) is a Hyderabad based Biotech company. SBIL manufacture and market bio pharmaceutical and recombinant protein products to medical and other industries.

SBIL is entering the capital markets with an initial public offering, IPO of 1,50,00,000 Equity Shares through a Fixed Price Issue.
 
The price for the issue has been fixed at Rs 10/- for equity share of Rs 10/-. The issue opens on September 25, 2007, and closes for subscription on September 28, 2007. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE).

Saamya Biotech IPO News & Events FAQs

The Saamya Biotech IPO is proposed to open on September 25, 2007. The IPO application ends on September 28, 2007.

Retail investors can apply in the retail or non-institutional investor category from September 25, 2007 to September 28, 2007. The Saamya Biotech IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).

The Saamya Biotech IPO will open for subscription on September 25, 2007. The public issue will close on September 28, 2007.